NCT04339036: CapTemY90 for Grade 2/3 NET Liver Metastases
- State
- Under way
- Phase
- Phase 2
- People
- 70 planned
- Started
- 7 Oct 2021
- Primary completion
- 1 Jul 2028
- Arms
- Oral CapTem + Y90 Radioembolization
- Results
- None posted
- 8 Apr 2020: Trial registered
- 7 Oct 2021: Trial started